180 participants
12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-04-25
- Start Date:
- 2002-04-30
- Completion:
- 2003-05-31
Conditions
- Parkinson's Disease
Interventions
- DRUG
No Results Yet